188 related articles for article (PubMed ID: 27836331)
1. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea.
Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB
J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331
[TBL] [Abstract][Full Text] [Related]
2. Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
Bang CH; Park HE; Kim YH; Jung JH; Lee JH; Park YM; Han JH
JAMA Dermatol; 2024 Feb; 160(2):194-198. PubMed ID: 38091023
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
4. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
Fan WC; Liu CJ; Hong YC; Feng JY; Su WJ; Chien SH; Chen TJ; Chiang CH
Int J Tuberc Lung Dis; 2015 Jan; 19(1):58-64. PubMed ID: 25519791
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
[TBL] [Abstract][Full Text] [Related]
6. High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation.
Zhang XH; Feng FE; Han W; Wang FR; Wang JZ; Wang Y; Chen Y; Fu HX; Mo XD; Zhang YY; Yan CH; Chen H; Chen YH; Liu Y; Xu LP; Liu KY; Huang XJ
Thromb Res; 2016 Aug; 144():6-11. PubMed ID: 27261538
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
8. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
9. Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.
Huang JT; Song JS; Hawryluk EB; London WB; Guo D; Sridharan M; Fisher DE; Lehmann LE; Duncan CN
J Am Acad Dermatol; 2018 Aug; 79(2):230-237. PubMed ID: 29588248
[TBL] [Abstract][Full Text] [Related]
10. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
11. Risk of osteoporosis and pathologic fractures in cancer patients who underwent hematopoietic stem cell transplantation: a nationwide retrospective cohort study.
Lin JN; Chen HJ; Yang CH; Lai CH; Lin HH; Chang CS; Liang JA
Oncotarget; 2017 May; 8(21):34811-34819. PubMed ID: 28422731
[TBL] [Abstract][Full Text] [Related]
12. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of graft-versus-host disease in patients after allogeneic stem cell transplantation].
Kozak I; Dwilewicz-Trojaczek J; Siemińska J; Górska R
Wiad Lek; 2011; 64(3):164-9. PubMed ID: 22335138
[TBL] [Abstract][Full Text] [Related]
16. [Study on chronic health conditions and its related risk factors in recipients after hematopoietic stem cell transplantation].
Song JJ; Ren HY; Qiu ZX; Wang MJ; Xu WL; Liu W; Li Y; Dong YJ; Yin Y; Sun YH; Wang LH; Ou JP; Wang WS; Cen XN
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):615-8. PubMed ID: 23134852
[TBL] [Abstract][Full Text] [Related]
17. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
[TBL] [Abstract][Full Text] [Related]
18. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
[TBL] [Abstract][Full Text] [Related]
19. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
20. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Kong Y; Hu Y; Zhang XH; Wang YZ; Mo XD; Zhang YY; Wang Y; Han W; Xu LP; Chang YJ; Huang XJ
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1190-7. PubMed ID: 24792870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
